India Glycols Appoints New MD and Directors
India Glycols Limited announced board resolutions approving the appointment of Ms. Pragya Bhartia Barwale as Managing Director for five years, subject to shareholder approval. Additionally, Mr. U.S. Bhartia, Ms. Pooja Jhaver, Mr. Malay Memani, Ms. Shukla Wassan, Ms. Bharati Agarwal, and Ms. Shilpa Divakar Nirula were appointed as Additional Directors, with Mr. Memani, Ms. Wassan, Ms. Agarwal, and Ms. Nirula designated as Independent Directors for three-year terms. These appointments are effective August 21, 2026, and are subject to shareholder consent. The company also provided an update regarding Ennature Bio Pharma Limited, enclosing material events as Annexure A, in line with stock exchange observation letters and SEBI regulations.
Key Highlights
- New Managing Director appointed for a 5-year term.
- Several new Additional Directors appointed, including Independent Directors.
- Appointments are subject to shareholder approval.
- Disclosure made regarding material updates from subsidiary Ennature Bio Pharma Limited.
- Company confirms directors are not debarred by SEBI or other authorities.
Price Impact
More from INDIAGLYCO